aluates Reports

$ 0.0

Automative

Global Central Nervous System Biomarker Detection Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-23W18796

BUY CHAPTERS

Global Central Nervous System Biomarker Detection Market Research Report 2025

Code: QYRE-Auto-23W18796

Report

March 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Central Nervous System Biomarker Detection Market Size

The global market for Central Nervous System Biomarker Detection was valued at US$ 8800 million in the year 2024 and is projected to reach a revised size of US$ 16460 million by 2031, growing at a CAGR of 9.4% during the forecast period.

Central Nervous System Biomarker Detection Market

Central nervous system biomarker detection refers to the identification of specific biomolecules or physiological indicators related to central nervous system diseases through measurement of body fluids (such as blood, cerebrospinal fluid) or imaging methods, for early diagnosis, disease monitoring, efficacy evaluation, and prognosis prediction of diseases. These biomarkers typically include proteins, genetic and epigenetic markers, metabolites, and imaging markers. The core value of the detection lies in improving the diagnostic accuracy of neurological diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, etc., and promoting the development of personalized medicine.

In recent years, the global market size for central nervous system biomarker detection has been continuously growing. The increasing burden of diseases, technological advancements, and the development of personalized medicine are the main driving factors. With the intensification of global aging, the number of patients with neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease has surged; The breakthroughs in gene sequencing and imaging technology have driven the discovery of biomarkers, and artificial intelligence and machine learning provide more accurate and efficient data analysis for biomarker detection; In addition, biomarkers play an important role in developing personalized healthcare plans, and all of these factors have promoted market expansion. In the global market, well-known companies such as Roche, Merck, Takeda, etc. have occupied a large market share with advanced research facilities, technology, and a large amount of resource investment, and have accumulated rich experience in research and clinical applications. Overall, local enterprises such as Dian Diagnostics are still in the catching up stage, and their competitiveness is gradually improving with the continuous breakthroughs in technology and the gradual expansion of the market. The challenges in the market mainly lie in technological bottlenecks, data privacy and ethical controversies over early diagnosis. The development trend of the future market is technological innovation, improvement of detection accuracy and efficiency, personalized and precise diagnosis and treatment, and further expansion of application fields.

This report aims to provide a comprehensive presentation of the global market for Central Nervous System Biomarker Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System Biomarker Detection.

The Central Nervous System Biomarker Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System Biomarker Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Central Nervous System Biomarker Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Central Nervous System Biomarker Detection Market Report

Report Metric	Details
Report Name	Central Nervous System Biomarker Detection Market
Accounted market size in year	US$ 8800 million
Forecasted market size in 2031	US$ 16460 million
CAGR	9.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Genetic Biomarkers Detection Protein Biomarkers Detection Metabolic Biomarkers Detection Neuroimaging Biomarkers Detection
Segment by Application	Disease Diagnosis And Classification Surveillance Prognosis Drug Development Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Merck, Takeda, Pfizer, GSK, Novartis, BristolMyers Squibb, Biogen, Celgene, AbbVie, Johnson And Johnson, Amgen, Eli Lilly, Sanofi, AstraZeneca, Quanterix, Biology Leader, Dian Diagnostics, Roadak, Delta Med Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System Biomarker Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Central Nervous System Biomarker Detection Market growing?

Ans: The Central Nervous System Biomarker Detection Market witnessing a CAGR of 9.4% during the forecast period 2025-2031.

What is the Central Nervous System Biomarker Detection Market size in 2031?

Ans: The Central Nervous System Biomarker Detection Market size in 2031 will be US$ 16460 million.

Who are the main players in the Central Nervous System Biomarker Detection Market report?

Ans: The main players in the Central Nervous System Biomarker Detection Market are Roche, Merck, Takeda, Pfizer, GSK, Novartis, BristolMyers Squibb, Biogen, Celgene, AbbVie, Johnson And Johnson, Amgen, Eli Lilly, Sanofi, AstraZeneca, Quanterix, Biology Leader, Dian Diagnostics, Roadak, Delta Med Biotech

What are the Application segmentation covered in the Central Nervous System Biomarker Detection Market report?

Ans: The Applications covered in the Central Nervous System Biomarker Detection Market report are Disease Diagnosis And Classification, Surveillance, Prognosis, Drug Development, Others

What are the Type segmentation covered in the Central Nervous System Biomarker Detection Market report?

Ans: The Types covered in the Central Nervous System Biomarker Detection Market report are Genetic Biomarkers Detection, Protein Biomarkers Detection, Metabolic Biomarkers Detection, Neuroimaging Biomarkers Detection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Central Nervous System Biomarker Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genetic Biomarkers Detection

1.2.3 Protein Biomarkers Detection

1.2.4 Metabolic Biomarkers Detection

1.2.5 Neuroimaging Biomarkers Detection

1.3 Market by Application

1.3.1 Global Central Nervous System Biomarker Detection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Disease Diagnosis And Classification

1.3.3 Surveillance

1.3.4 Prognosis

1.3.5 Drug Development

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Central Nervous System Biomarker Detection Market Perspective (2020-2031)

2.2 Global Central Nervous System Biomarker Detection Growth Trends by Region

2.2.1 Global Central Nervous System Biomarker Detection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Central Nervous System Biomarker Detection Historic Market Size by Region (2020-2025)

2.2.3 Central Nervous System Biomarker Detection Forecasted Market Size by Region (2026-2031)

2.3 Central Nervous System Biomarker Detection Market Dynamics

2.3.1 Central Nervous System Biomarker Detection Industry Trends

2.3.2 Central Nervous System Biomarker Detection Market Drivers

2.3.3 Central Nervous System Biomarker Detection Market Challenges

2.3.4 Central Nervous System Biomarker Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Central Nervous System Biomarker Detection Players by Revenue

3.1.1 Global Top Central Nervous System Biomarker Detection Players by Revenue (2020-2025)

3.1.2 Global Central Nervous System Biomarker Detection Revenue Market Share by Players (2020-2025)

3.2 Global Top Central Nervous System Biomarker Detection Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Central Nervous System Biomarker Detection Revenue

3.4 Global Central Nervous System Biomarker Detection Market Concentration Ratio

3.4.1 Global Central Nervous System Biomarker Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Biomarker Detection Revenue in 2024

3.5 Global Key Players of Central Nervous System Biomarker Detection Head office and Area Served

3.6 Global Key Players of Central Nervous System Biomarker Detection, Product and Application

3.7 Global Key Players of Central Nervous System Biomarker Detection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System Biomarker Detection Breakdown Data by Type

4.1 Global Central Nervous System Biomarker Detection Historic Market Size by Type (2020-2025)

4.2 Global Central Nervous System Biomarker Detection Forecasted Market Size by Type (2026-2031)

5 Central Nervous System Biomarker Detection Breakdown Data by Application

5.1 Global Central Nervous System Biomarker Detection Historic Market Size by Application (2020-2025)

5.2 Global Central Nervous System Biomarker Detection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Central Nervous System Biomarker Detection Market Size (2020-2031)

6.2 North America Central Nervous System Biomarker Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Central Nervous System Biomarker Detection Market Size by Country (2020-2025)

6.4 North America Central Nervous System Biomarker Detection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Central Nervous System Biomarker Detection Market Size (2020-2031)

7.2 Europe Central Nervous System Biomarker Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Central Nervous System Biomarker Detection Market Size by Country (2020-2025)

7.4 Europe Central Nervous System Biomarker Detection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Central Nervous System Biomarker Detection Market Size (2020-2031)

8.2 Asia-Pacific Central Nervous System Biomarker Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Central Nervous System Biomarker Detection Market Size by Region (2020-2025)

8.4 Asia-Pacific Central Nervous System Biomarker Detection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Central Nervous System Biomarker Detection Market Size (2020-2031)

9.2 Latin America Central Nervous System Biomarker Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Central Nervous System Biomarker Detection Market Size by Country (2020-2025)

9.4 Latin America Central Nervous System Biomarker Detection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Central Nervous System Biomarker Detection Market Size (2020-2031)

10.2 Middle East & Africa Central Nervous System Biomarker Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Central Nervous System Biomarker Detection Market Size by Country (2020-2025)

10.4 Middle East & Africa Central Nervous System Biomarker Detection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Central Nervous System Biomarker Detection Introduction

11.1.4 Roche Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Central Nervous System Biomarker Detection Introduction

11.2.4 Merck Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Takeda

11.3.1 Takeda Company Details

11.3.2 Takeda Business Overview

11.3.3 Takeda Central Nervous System Biomarker Detection Introduction

11.3.4 Takeda Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.3.5 Takeda Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Central Nervous System Biomarker Detection Introduction

11.4.4 Pfizer Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 GSK

11.5.1 GSK Company Details

11.5.2 GSK Business Overview

11.5.3 GSK Central Nervous System Biomarker Detection Introduction

11.5.4 GSK Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.5.5 GSK Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Central Nervous System Biomarker Detection Introduction

11.6.4 Novartis Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 BristolMyers Squibb

11.7.1 BristolMyers Squibb Company Details

11.7.2 BristolMyers Squibb Business Overview

11.7.3 BristolMyers Squibb Central Nervous System Biomarker Detection Introduction

11.7.4 BristolMyers Squibb Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.7.5 BristolMyers Squibb Recent Development

11.8 Biogen

11.8.1 Biogen Company Details

11.8.2 Biogen Business Overview

11.8.3 Biogen Central Nervous System Biomarker Detection Introduction

11.8.4 Biogen Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.8.5 Biogen Recent Development

11.9 Celgene

11.9.1 Celgene Company Details

11.9.2 Celgene Business Overview

11.9.3 Celgene Central Nervous System Biomarker Detection Introduction

11.9.4 Celgene Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.9.5 Celgene Recent Development

11.10 AbbVie

11.10.1 AbbVie Company Details

11.10.2 AbbVie Business Overview

11.10.3 AbbVie Central Nervous System Biomarker Detection Introduction

11.10.4 AbbVie Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.10.5 AbbVie Recent Development

11.11 Johnson And Johnson

11.11.1 Johnson And Johnson Company Details

11.11.2 Johnson And Johnson Business Overview

11.11.3 Johnson And Johnson Central Nervous System Biomarker Detection Introduction

11.11.4 Johnson And Johnson Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.11.5 Johnson And Johnson Recent Development

11.12 Amgen

11.12.1 Amgen Company Details

11.12.2 Amgen Business Overview

11.12.3 Amgen Central Nervous System Biomarker Detection Introduction

11.12.4 Amgen Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.12.5 Amgen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Central Nervous System Biomarker Detection Introduction

11.13.4 Eli Lilly Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.13.5 Eli Lilly Recent Development

11.14 Sanofi

11.14.1 Sanofi Company Details

11.14.2 Sanofi Business Overview

11.14.3 Sanofi Central Nervous System Biomarker Detection Introduction

11.14.4 Sanofi Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.14.5 Sanofi Recent Development

11.15 AstraZeneca

11.15.1 AstraZeneca Company Details

11.15.2 AstraZeneca Business Overview

11.15.3 AstraZeneca Central Nervous System Biomarker Detection Introduction

11.15.4 AstraZeneca Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.15.5 AstraZeneca Recent Development

11.16 Quanterix

11.16.1 Quanterix Company Details

11.16.2 Quanterix Business Overview

11.16.3 Quanterix Central Nervous System Biomarker Detection Introduction

11.16.4 Quanterix Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.16.5 Quanterix Recent Development

11.17 Biology Leader

11.17.1 Biology Leader Company Details

11.17.2 Biology Leader Business Overview

11.17.3 Biology Leader Central Nervous System Biomarker Detection Introduction

11.17.4 Biology Leader Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.17.5 Biology Leader Recent Development

11.18 Dian Diagnostics

11.18.1 Dian Diagnostics Company Details

11.18.2 Dian Diagnostics Business Overview

11.18.3 Dian Diagnostics Central Nervous System Biomarker Detection Introduction

11.18.4 Dian Diagnostics Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.18.5 Dian Diagnostics Recent Development

11.19 Roadak

11.19.1 Roadak Company Details

11.19.2 Roadak Business Overview

11.19.3 Roadak Central Nervous System Biomarker Detection Introduction

11.19.4 Roadak Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.19.5 Roadak Recent Development

11.20 Delta Med Biotech

11.20.1 Delta Med Biotech Company Details

11.20.2 Delta Med Biotech Business Overview

11.20.3 Delta Med Biotech Central Nervous System Biomarker Detection Introduction

11.20.4 Delta Med Biotech Revenue in Central Nervous System Biomarker Detection Business (2020-2025)

11.20.5 Delta Med Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Central Nervous System Biomarker Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genetic Biomarkers Detection

Table 3. Key Players of Protein Biomarkers Detection

Table 4. Key Players of Metabolic Biomarkers Detection

Table 5. Key Players of Neuroimaging Biomarkers Detection

Table 6. Global Central Nervous System Biomarker Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Central Nervous System Biomarker Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Central Nervous System Biomarker Detection Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Central Nervous System Biomarker Detection Market Share by Region (2020-2025)

Table 10. Global Central Nervous System Biomarker Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Central Nervous System Biomarker Detection Market Share by Region (2026-2031)

Table 12. Central Nervous System Biomarker Detection Market Trends

Table 13. Central Nervous System Biomarker Detection Market Drivers

Table 14. Central Nervous System Biomarker Detection Market Challenges

Table 15. Central Nervous System Biomarker Detection Market Restraints

Table 16. Global Central Nervous System Biomarker Detection Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Central Nervous System Biomarker Detection Market Share by Players (2020-2025)

Table 18. Global Top Central Nervous System Biomarker Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarker Detection as of 2024)

Table 19. Ranking of Global Top Central Nervous System Biomarker Detection Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Central Nervous System Biomarker Detection Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Central Nervous System Biomarker Detection, Headquarters and Area Served

Table 22. Global Key Players of Central Nervous System Biomarker Detection, Product and Application

Table 23. Global Key Players of Central Nervous System Biomarker Detection, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Central Nervous System Biomarker Detection Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Central Nervous System Biomarker Detection Revenue Market Share by Type (2020-2025)

Table 27. Global Central Nervous System Biomarker Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Central Nervous System Biomarker Detection Revenue Market Share by Type (2026-2031)

Table 29. Global Central Nervous System Biomarker Detection Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Central Nervous System Biomarker Detection Revenue Market Share by Application (2020-2025)

Table 31. Global Central Nervous System Biomarker Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Central Nervous System Biomarker Detection Revenue Market Share by Application (2026-2031)

Table 33. North America Central Nervous System Biomarker Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Central Nervous System Biomarker Detection Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Central Nervous System Biomarker Detection Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Central Nervous System Biomarker Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Central Nervous System Biomarker Detection Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Central Nervous System Biomarker Detection Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Central Nervous System Biomarker Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Central Nervous System Biomarker Detection Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Central Nervous System Biomarker Detection Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Central Nervous System Biomarker Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Central Nervous System Biomarker Detection Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Central Nervous System Biomarker Detection Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Central Nervous System Biomarker Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Central Nervous System Biomarker Detection Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Central Nervous System Biomarker Detection Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Central Nervous System Biomarker Detection Product

Table 51. Roche Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Merck Company Details

Table 54. Merck Business Overview

Table 55. Merck Central Nervous System Biomarker Detection Product

Table 56. Merck Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 57. Merck Recent Development

Table 58. Takeda Company Details

Table 59. Takeda Business Overview

Table 60. Takeda Central Nervous System Biomarker Detection Product

Table 61. Takeda Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 62. Takeda Recent Development

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Central Nervous System Biomarker Detection Product

Table 66. Pfizer Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 67. Pfizer Recent Development

Table 68. GSK Company Details

Table 69. GSK Business Overview

Table 70. GSK Central Nervous System Biomarker Detection Product

Table 71. GSK Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 72. GSK Recent Development

Table 73. Novartis Company Details

Table 74. Novartis Business Overview

Table 75. Novartis Central Nervous System Biomarker Detection Product

Table 76. Novartis Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 77. Novartis Recent Development

Table 78. BristolMyers Squibb Company Details

Table 79. BristolMyers Squibb Business Overview

Table 80. BristolMyers Squibb Central Nervous System Biomarker Detection Product

Table 81. BristolMyers Squibb Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 82. BristolMyers Squibb Recent Development

Table 83. Biogen Company Details

Table 84. Biogen Business Overview

Table 85. Biogen Central Nervous System Biomarker Detection Product

Table 86. Biogen Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 87. Biogen Recent Development

Table 88. Celgene Company Details

Table 89. Celgene Business Overview

Table 90. Celgene Central Nervous System Biomarker Detection Product

Table 91. Celgene Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 92. Celgene Recent Development

Table 93. AbbVie Company Details

Table 94. AbbVie Business Overview

Table 95. AbbVie Central Nervous System Biomarker Detection Product

Table 96. AbbVie Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 97. AbbVie Recent Development

Table 98. Johnson And Johnson Company Details

Table 99. Johnson And Johnson Business Overview

Table 100. Johnson And Johnson Central Nervous System Biomarker Detection Product

Table 101. Johnson And Johnson Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 102. Johnson And Johnson Recent Development

Table 103. Amgen Company Details

Table 104. Amgen Business Overview

Table 105. Amgen Central Nervous System Biomarker Detection Product

Table 106. Amgen Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 107. Amgen Recent Development

Table 108. Eli Lilly Company Details

Table 109. Eli Lilly Business Overview

Table 110. Eli Lilly Central Nervous System Biomarker Detection Product

Table 111. Eli Lilly Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 112. Eli Lilly Recent Development

Table 113. Sanofi Company Details

Table 114. Sanofi Business Overview

Table 115. Sanofi Central Nervous System Biomarker Detection Product

Table 116. Sanofi Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 117. Sanofi Recent Development

Table 118. AstraZeneca Company Details

Table 119. AstraZeneca Business Overview

Table 120. AstraZeneca Central Nervous System Biomarker Detection Product

Table 121. AstraZeneca Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 122. AstraZeneca Recent Development

Table 123. Quanterix Company Details

Table 124. Quanterix Business Overview

Table 125. Quanterix Central Nervous System Biomarker Detection Product

Table 126. Quanterix Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 127. Quanterix Recent Development

Table 128. Biology Leader Company Details

Table 129. Biology Leader Business Overview

Table 130. Biology Leader Central Nervous System Biomarker Detection Product

Table 131. Biology Leader Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 132. Biology Leader Recent Development

Table 133. Dian Diagnostics Company Details

Table 134. Dian Diagnostics Business Overview

Table 135. Dian Diagnostics Central Nervous System Biomarker Detection Product

Table 136. Dian Diagnostics Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 137. Dian Diagnostics Recent Development

Table 138. Roadak Company Details

Table 139. Roadak Business Overview

Table 140. Roadak Central Nervous System Biomarker Detection Product

Table 141. Roadak Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 142. Roadak Recent Development

Table 143. Delta Med Biotech Company Details

Table 144. Delta Med Biotech Business Overview

Table 145. Delta Med Biotech Central Nervous System Biomarker Detection Product

Table 146. Delta Med Biotech Revenue in Central Nervous System Biomarker Detection Business (2020-2025) & (US$ Million)

Table 147. Delta Med Biotech Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Central Nervous System Biomarker Detection Picture

Figure 2. Global Central Nervous System Biomarker Detection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Central Nervous System Biomarker Detection Market Share by Type: 2024 VS 2031

Figure 4. Genetic Biomarkers Detection Features

Figure 5. Protein Biomarkers Detection Features

Figure 6. Metabolic Biomarkers Detection Features

Figure 7. Neuroimaging Biomarkers Detection Features

Figure 8. Global Central Nervous System Biomarker Detection Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Central Nervous System Biomarker Detection Market Share by Application: 2024 VS 2031

Figure 10. Disease Diagnosis And Classification Case Studies

Figure 11. Surveillance Case Studies

Figure 12. Prognosis Case Studies

Figure 13. Drug Development Case Studies

Figure 14. Others Case Studies

Figure 15. Central Nervous System Biomarker Detection Report Years Considered

Figure 16. Global Central Nervous System Biomarker Detection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Central Nervous System Biomarker Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Central Nervous System Biomarker Detection Market Share by Region: 2024 VS 2031

Figure 19. Global Central Nervous System Biomarker Detection Market Share by Players in 2024

Figure 20. Global Central Nervous System Biomarker Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Central Nervous System Biomarker Detection Revenue in 2024

Figure 22. North America Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Central Nervous System Biomarker Detection Market Share by Country (2020-2031)

Figure 24. United States Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Central Nervous System Biomarker Detection Market Share by Country (2020-2031)

Figure 28. Germany Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Central Nervous System Biomarker Detection Market Share by Region (2020-2031)

Figure 36. China Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Central Nervous System Biomarker Detection Market Share by Country (2020-2031)

Figure 44. Mexico Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Central Nervous System Biomarker Detection Market Share by Country (2020-2031)

Figure 48. Turkey Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Central Nervous System Biomarker Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Roche Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 53. Takeda Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 55. GSK Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 57. BristolMyers Squibb Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 58. Biogen Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 59. Celgene Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 60. AbbVie Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 61. Johnson And Johnson Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 62. Amgen Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 63. Eli Lilly Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 64. Sanofi Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 65. AstraZeneca Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 66. Quanterix Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 67. Biology Leader Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 68. Dian Diagnostics Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 69. Roadak Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 70. Delta Med Biotech Revenue Growth Rate in Central Nervous System Biomarker Detection Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nervous System Markers Market Research Report 2025

Global Biomarker Detection Systems Market Research Report 2024

Global Brain Biomarker Market Research Report 2024

Global Alzheimer s Blood Tests Market Research Report 2024

Global Oncology Biomarker Market Insights Forecast to 2030

Global Blood Tests for Alzheimer s Diagnosis Market Research Report 2024

Global Commercializing Biomarkers Market Research Report 2025

Protein Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Biomarker Market Research Report 2024

Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030

Global Alzheimer s Disease Blood Diagnostic Market Research Report 2024

Global Blood based Biomarker Market Research Report 2025

Global Central Nervous System Nanomedicines Market Research Report 2025

Global Cerebrospinal Fluid Testing Service Market Research Report 2024

Global Neural Biosensors Market Research Report 2025

Global Protein Detection Systems Market Research Report 2024

Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-35H13194

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30P9123

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Othe-477

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9W6217

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Central Nervous System Biomarker Detection Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-23W18796

Global Central Nervous System Biomarker Detection Market Research Report 2025

FEATURED COMPANIES

Central Nervous System Biomarker Detection Market Size

Central Nervous System Biomarker Detection Market

Scope of Central Nervous System Biomarker Detection Market Report

Chapter Outline

FAQ for this report

How fast is Central Nervous System Biomarker Detection Market growing?

What is the Central Nervous System Biomarker Detection Market size in 2031?

Who are the main players in the Central Nervous System Biomarker Detection Market report?

What are the Application segmentation covered in the Central Nervous System Biomarker Detection Market report?

What are the Type segmentation covered in the Central Nervous System Biomarker Detection Market report?

FEATURED COMPANIES

RELATED REPORTS